CS

Chillara Sivaanjaneya Prasad

Active Director Director DIN 10955955
DIN 10955955 First appointment Feb 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Chillara Sivaanjaneya Prasad

Data last updated:

Chillara Sivaanjaneya Prasad is a Director at Rametus Healthcare Private Limited (since 2025). The company operates in Paper.

DIN 10955955
Primary Designation Director
Industry Paper
First Appointment 18 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rametus Healthcare Private Limited U21001MH2025PTC440408
Director18 Feb 20252025Active

Board colleagues of Chillara Sivaanjaneya Prasad

Directorship timeline

Open interactive timeline →
Rametus Healthcare Private Limited
Premium access

Shareholding and investment profile for Chillara Sivaanjaneya Prasad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chillara Sivaanjaneya Prasad

Chillara Sivaanjaneya Prasad currently holds 1 directorship: Rametus Healthcare Private Limited (Director, since 18 Feb 2025).

Chillara Sivaanjaneya Prasad was first appointed on 18 Feb 2025 as Director at Rametus Healthcare Private Limited.

The current boards of Chillara Sivaanjaneya Prasad's companies include Subbarao Dintakurti (Rametus Healthcare Private Limited), Venkateswara Rao Yebbili (Rametus Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available